<p>KORU Medical Systems, Inc.（纳斯达克代码：KRMD - 获取免费报告）目前获得了六家评级机构的 “适度买入” 共识评级，Marketbeat 报道称。一位研究分析师给予该股票卖出评级，一位给予持有评级，三位给予买入评级，还有一位给予强烈买入评级。在过去一年中，发布报告的分析师对该股票的平均一年目标价为 5.1250 美元。</p>
<p>多位研究分析师最近对该公司进行了评论。Canaccord Genuity Group 在周三对 KORU Medical Systems 设定了 6.00 美元的目标价，并给予该股票 “买入” 评级。Weiss Ratings 在 10 月 8 日的报告中重申了对 KORU Medical Systems 股票的 “卖出（d-）” 评级。</p>
<p>获取 <strong>KORU Medical Systems</strong> 的提醒：</p>
<p><strong>获取我们关于 KORU Medical Systems 的最新股票报告</strong></p>
<h2>KORU Medical Systems 股票下跌 5.3%</h2>
<p>KRMD 股票在周三下跌 0.31 美元，报 5.47 美元。该公司的股票交易量为 49,708 股，而其平均交易量为 172,944 股。该公司的 50 日移动平均价格为 4.66 美元，200 日移动平均价格为 4.03 美元。KORU Medical Systems 的 52 周低点为 1.86 美元，52 周高点为 6.11 美元。该公司的速动比率为 1.92，流动比率为 2.48，债务与股本比率为 0.01。该公司的市值为 2.5314 亿美元，市盈率为-68.31，贝塔值为 0.58。</p>
<h2>机构投资者对 KORU Medical Systems 的看法</h2>
<p>对冲基金和其他机构投资者最近买卖了该公司的股票。Connor Clark &amp; Lunn Investment Management Ltd. 在第一季度将其在 KORU Medical Systems 的持股增加了 11.8%。Connor Clark &amp; Lunn Investment Management Ltd. 现在拥有 66,917 股该公司的股票，价值 170,000 美元，在此期间又购买了 7,046 股。HighTower Advisors LLC 在第一季度将其在 KORU Medical Systems 的持股增加了 18.4%。HighTower Advisors LLC 现在拥有 51,400 股该公司的股票，价值 131,000 美元，在上个季度又收购了 8,000 股。Russell Investments Group Ltd. 在第一季度将其在 KORU Medical Systems 的持股增加了 220.5%。Russell Investments Group Ltd. 现在拥有 214,908 股该公司的股票，价值 546,000 美元，在此期间又收购了 147,857 股。OMERS ADMINISTRATION Corp 在第一季度收购了 KORU Medical Systems 的新股份，价值约 239,000 美元。最后，Cubist Systematic Strategies LLC 在第一季度将其在 KORU Medical Systems 的持股增加了 927.4%。Cubist Systematic Strategies LLC 现在拥有 77,280 股该公司的股票，价值 196,000 美元，在上个季度又收购了 69,758 股。机构投资者持有该公司 58.60% 的股票。</p>
<h2>KORU Medical Systems 公司简介</h2>
<p>（获取免费报告）</p>
<p>KORU Medical Systems, Inc. 在美国和国际上开发和制造医疗设备和用品。它提供自由输注系统，以向患有慢性疾病的患者提供救命疗法，例如原发性免疫缺陷疾病、慢性炎性脱髓鞘多发性神经病和阵发性夜间血红蛋白尿。</p>
<h2>特色文章</h2>
<ul>
<li>五只我们更看好的股票，而不是 KORU Medical Systems</li>
<li>股票平均计算器</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
<li>如何利用高贝塔股票最大化投资利润</li>
<li>特斯拉被高估了吗？可能是便宜货的两个理由</li>
<li>什么是股息挑战者？</li>
<li>这两只股票如何赢得 2025 年的人工智能竞赛——2026 年又将如何</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S1JNRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S1JNRA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 KORU Medical Systems 吗？</h2>
<p>在你考虑 KORU Medical Systems 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 KORU Medical Systems 并不在名单上。</p>
<p>虽然 KORU Medical Systems 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

KRMD

<p>KORU Medical Systems, Inc.（纳斯达克代码：KRMD）获得了六家评级公司的 “适度买入” 共识评级。该股票有一个卖出评级，一个持有评级，三个买入评级和一个强烈买入评级。平均一年价格目标为 5.1250 美元。该股票最近交易价格为 5.47 美元，下跌 5.3%。机构投资者持有该公司 58.60% 的股票。KORU Medical Systems 开发和制造医疗设备及用品</p>

<p>KORU Medical Systems, Inc. (NASDAQ:KRMD - Get Free Report) has been given a consensus rating of &#34;Moderate Buy&#34; by the six ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $5.1250.</p>
<div class="lb-trans"><p>KORU Medical Systems, Inc.（纳斯达克代码：KRMD - 获取免费报告）目前获得了六家评级机构的 “适度买入” 共识评级，Marketbeat 报道称。一位研究分析师给予该股票卖出评级，一位给予持有评级，三位给予买入评级，还有一位给予强烈买入评级。在过去一年中，发布报告的分析师对该股票的平均一年目标价为 5.1250 美元。</p>
</div><p>A number of research analysts recently commented on the company. Canaccord Genuity Group set a $6.00 price target on KORU Medical Systems and gave the stock a &#34;buy&#34; rating in a research report on Wednesday. Weiss Ratings reaffirmed a &#34;sell (d-)&#34; rating on shares of KORU Medical Systems in a report on Wednesday, October 8th.</p>
<div class="lb-trans"><p>多位研究分析师最近对该公司进行了评论。Canaccord Genuity Group 在周三对 KORU Medical Systems 设定了 6.00 美元的目标价，并给予该股票 “买入” 评级。Weiss Ratings 在 10 月 8 日的报告中重申了对 KORU Medical Systems 股票的 “卖出（d-）” 评级。</p>
</div><p>Get <strong>KORU Medical Systems</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>KORU Medical Systems</strong> 的提醒：</p>
</div><p><strong>Get Our Latest Stock Report on KORU Medical Systems</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 KORU Medical Systems 的最新股票报告</strong></p>
</div><h2>KORU Medical Systems Stock Down 5.3%</h2>
<div class="lb-trans"><h2>KORU Medical Systems 股票下跌 5.3%</h2>
</div><p>Shares of KRMD traded down $0.31 on Wednesday, hitting $5.47. The company's stock had a trading volume of 49,708 shares, compared to its average volume of 172,944. The firm's fifty day moving average price is $4.66 and its 200-day moving average price is $4.03. KORU Medical Systems has a fifty-two week low of $1.86 and a fifty-two week high of $6.11. The company has a quick ratio of 1.92, a current ratio of 2.48 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $253.14 million, a price-to-earnings ratio of -68.31 and a beta of 0.58.</p>
<div class="lb-trans"><p>KRMD 股票在周三下跌 0.31 美元，报 5.47 美元。该公司的股票交易量为 49,708 股，而其平均交易量为 172,944 股。该公司的 50 日移动平均价格为 4.66 美元，200 日移动平均价格为 4.03 美元。KORU Medical Systems 的 52 周低点为 1.86 美元，52 周高点为 6.11 美元。该公司的速动比率为 1.92，流动比率为 2.48，债务与股本比率为 0.01。该公司的市值为 2.5314 亿美元，市盈率为-68.31，贝塔值为 0.58。</p>
</div><h2>Institutional Investors Weigh In On KORU Medical Systems</h2>
<div class="lb-trans"><h2>机构投资者对 KORU Medical Systems 的看法</h2>
</div><p>Hedge funds and other institutional investors have recently bought and sold shares of the company. Connor Clark &amp; Lunn Investment Management Ltd. increased its position in shares of KORU Medical Systems by 11.8% during the first quarter. Connor Clark &amp; Lunn Investment Management Ltd. now owns 66,917 shares of the company's stock worth $170,000 after buying an additional 7,046 shares during the period. HighTower Advisors LLC boosted its position in KORU Medical Systems by 18.4% during the first quarter. HighTower Advisors LLC now owns 51,400 shares of the company's stock valued at $131,000 after acquiring an additional 8,000 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in KORU Medical Systems by 220.5% during the 1st quarter. Russell Investments Group Ltd. now owns 214,908 shares of the company's stock worth $546,000 after acquiring an additional 147,857 shares during the period. OMERS ADMINISTRATION Corp acquired a new stake in KORU Medical Systems during the 1st quarter worth about $239,000. Finally, Cubist Systematic Strategies LLC raised its position in shares of KORU Medical Systems by 927.4% in the 1st quarter. Cubist Systematic Strategies LLC now owns 77,280 shares of the company's stock worth $196,000 after acquiring an additional 69,758 shares in the last quarter. Institutional investors own 58.60% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近买卖了该公司的股票。Connor Clark &amp; Lunn Investment Management Ltd. 在第一季度将其在 KORU Medical Systems 的持股增加了 11.8%。Connor Clark &amp; Lunn Investment Management Ltd. 现在拥有 66,917 股该公司的股票，价值 170,000 美元，在此期间又购买了 7,046 股。HighTower Advisors LLC 在第一季度将其在 KORU Medical Systems 的持股增加了 18.4%。HighTower Advisors LLC 现在拥有 51,400 股该公司的股票，价值 131,000 美元，在上个季度又收购了 8,000 股。Russell Investments Group Ltd. 在第一季度将其在 KORU Medical Systems 的持股增加了 220.5%。Russell Investments Group Ltd. 现在拥有 214,908 股该公司的股票，价值 546,000 美元，在此期间又收购了 147,857 股。OMERS ADMINISTRATION Corp 在第一季度收购了 KORU Medical Systems 的新股份，价值约 239,000 美元。最后，Cubist Systematic Strategies LLC 在第一季度将其在 KORU Medical Systems 的持股增加了 927.4%。Cubist Systematic Strategies LLC 现在拥有 77,280 股该公司的股票，价值 196,000 美元，在上个季度又收购了 69,758 股。机构投资者持有该公司 58.60% 的股票。</p>
</div><h2>KORU Medical Systems Company Profile</h2>
<div class="lb-trans"><h2>KORU Medical Systems 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.</p>
<div class="lb-trans"><p>KORU Medical Systems, Inc. 在美国和国际上开发和制造医疗设备和用品。它提供自由输注系统，以向患有慢性疾病的患者提供救命疗法，例如原发性免疫缺陷疾病、慢性炎性脱髓鞘多发性神经病和阵发性夜间血红蛋白尿。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than KORU Medical Systems</li>
<li>Stock Average Calculator</li>
<li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li>
<li>How to Use High Beta Stocks to Maximize Your Investing Profits</li>
<li>Is Tesla Overvalued? 2 Reasons It Might Be a Bargain</li>
<li>What Are Dividend Challengers?</li>
<li>How These 2 Stocks Won 2025's AI Race—And What's In Store for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，而不是 KORU Medical Systems</li>
<li>股票平均计算器</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
<li>如何利用高贝塔股票最大化投资利润</li>
<li>特斯拉被高估了吗？可能是便宜货的两个理由</li>
<li>什么是股息挑战者？</li>
<li>这两只股票如何赢得 2025 年的人工智能竞赛——2026 年又将如何</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S1JNRA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=KRMD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in KORU Medical Systems Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 KORU Medical Systems 吗？</h2>
</div><p>Before you consider KORU Medical Systems, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 KORU Medical Systems 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 KORU Medical Systems 并不在名单上。</p>
</div><p>While KORU Medical Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 KORU Medical Systems 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

分析师给予 KORU Medical Systems, Inc. (NASDAQ:KRMD)“适度买入” 的平均推荐